Female pseudohermaphroditism is an older medical term for a condition in which a person has XX chromosomes and ovaries but is born with external genitalia that appear partly or fully masculinized. The term itself has largely fallen out of clinical use, replaced by “46,XX disorder of sex development” (46,XX DSD) after a 2005 international consensus determined that older labels were confusing and potentially hurtful. Still, the older name persists in medical literature, search engines, and the memories of families who received the diagnosis years ago, so understanding what it refers to and what causes it remains relevant.
Why the Name Changed
For most of the twentieth century, clinicians sorted atypical genital anatomy into categories like “intersex,” “hermaphrodite,” and “pseudohermaphrodite.” The word “pseudo” implied the condition was somehow fake, which understandably frustrated patients and their families. A 2005 consensus conference in Chicago recommended replacing the entire scheme with the umbrella term “disorders of sex development,” using the person’s chromosome pattern as a prefix. What was once called female pseudohermaphroditism became 46,XX DSD; what was called male pseudohermaphroditism became 46,XY DSD.1PubMed. Disorders of sex development: a new definition and classification The updated terminology is now standard in pediatric endocrinology and urology guidelines, though the older terms still surface in legacy textbooks and case reports.2PubMed Central. Disorders of sex development
How Fetal Genitalia Become Masculinized
Early in pregnancy, all embryos start with the same undifferentiated genital structures. In a typical XX fetus, low levels of androgens allow those structures to develop into a clitoris, labia, and separate urethral and vaginal openings. If androgen levels climb abnormally high during the critical window of genital development, those same tissues can follow a more masculinized path: the clitoris enlarges, the labial folds partially or completely fuse, and the urethral and vaginal openings may merge into a single channel. The ovaries themselves develop normally because ovarian differentiation does not depend on androgen levels. This is the core of every case that falls under this diagnosis: normal internal female organs paired with external anatomy that has been reshaped by excess androgens before birth.
Congenital Adrenal Hyperplasia, the Most Common Cause
By far the most frequent reason an XX fetus is exposed to excess androgens is congenital adrenal hyperplasia (CAH), and the most common form of CAH involves a deficiency of the enzyme 21-hydroxylase. When this enzyme is missing or severely reduced, the adrenal glands cannot produce cortisol efficiently. The body responds by ramping up signals to the adrenals, which drives precursor hormones down alternate pathways that produce androgens instead. In the most severe “salt-wasting” form, there is almost no residual enzyme activity, so both cortisol and aldosterone are deficient while androgen production soars. The result in a female fetus can range from mild clitoral enlargement to genitalia that look fully male, complete with what appears to be a penis and an empty scrotum, even though ovaries and a uterus are present internally.3Oxford Academic. Genetics and Pathophysiology of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
The salt-wasting form carries an immediate danger beyond genital anatomy. Without aldosterone, newborns cannot retain sodium properly. In the first days to weeks of life, they can develop vomiting, dehydration, dangerously low blood pressure, and potentially fatal adrenal crisis. This is why newborn screening programs in many countries now test for CAH by measuring a hormone marker called 17-hydroxyprogesterone from a heel-stick blood sample. In New Zealand’s screening program, for instance, treatment was typically started by about twelve days of age in babies caught by screening, and none of those babies had progressed to full cardiovascular collapse at diagnosis.4The Journal of Clinical Endocrinology & Metabolism. Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand, 1994–2013 Screening is especially critical for female newborns who happen to have minimal external virilization, because without obvious genital changes there is no visual clue that anything is wrong, and a salt-wasting crisis can develop before anyone suspects CAH.5Journal of the Endocrine Society. ODP375 Absence of Virilization With Completely Normal Phenotype in a Newborn Female With Salt-Wasting Classical CAH
Less Common Causes
While 21-hydroxylase deficiency accounts for the vast majority of cases, a handful of other conditions can produce similar genital findings in an XX individual.
11β-Hydroxylase Deficiency
This is the second most common form of CAH, though still far rarer than 21-hydroxylase deficiency. The enzyme block sits at a different step in the cortisol production pathway, but the downstream effect is similar: precursor hormones are shunted toward androgens, and female fetuses can be virilized to varying degrees. A distinguishing feature is that about half of affected patients develop high blood pressure, because a mineralocorticoid precursor (deoxycorticosterone) accumulates upstream of the block.6Arq Bras Endocrinol Metab. 11beta-hydroxylase deficiency In boys, the condition tends to present later in childhood as early puberty, while in girls the virilized genitalia at birth usually prompt earlier investigation.7PubMed Central. Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency in a Tunisian family
Placental Aromatase Deficiency
Aromatase is the enzyme that converts androgens into estrogens. The placenta normally acts as a buffer, aromatizing fetal and maternal androgens so they do not accumulate. When the fetus carries mutations that disable aromatase, both the mother and the fetus become exposed to high androgen levels. The mother may develop deepening of the voice, acne, and excess body hair during the pregnancy, and the female fetus can be born with virilized genitalia. This was first documented in a landmark case report that described concurrent maternal virilization and fetal pseudohermaphroditism traced to absent placental aromatase activity.8The Journal of Clinical Endocrinology & Metabolism. A New Cause of Female Pseudohermaphroditism: Placental Aromatase Deficiency Subsequent molecular studies confirmed the genetic basis.9The Journal of Steroid Biochemistry and Molecular Biology. Genetic analysis of human placental aromatase deficiency The condition is very rare, but it is notable because the source of excess androgen is not the fetal adrenal glands but rather a failure to clear androgens that are already circulating.
Maternal Sources of Androgens
Occasionally the excess androgens come from the mother herself. A pregnancy luteoma is a benign ovarian growth that appears during pregnancy and typically shrinks on its own after delivery. Roughly a quarter of luteomas secrete androgens, and when levels climb high enough, the hormones can cross the placenta and virilize a female fetus.10ESPE Abstracts. Maternal Ovarian Luteoma Causing Complete Virilization of a Female Fetus Case reports describe infants born with clitoral enlargement and labial fusion whose mothers were found to have elevated testosterone levels at delivery, with the luteoma discovered incidentally during cesarean section.11PubMed. Luteoma-induced fetal virilization Because the tumor resolves postpartum, the infant’s androgen exposure stops at birth, and further virilization does not progress. Theca-lutein cysts are another ovarian source of excess androgens during pregnancy, though they are also uncommon.12PubMed Central. Ovarian luteoma masses in pregnancy: an uncommon cause of virilisation
How Virilization Is Graded
Clinicians use the Prader scale to describe how much the external genitalia have been masculinized, ranging from stage I (mild clitoral enlargement with normal labial separation) to stage V (genitalia that appear fully male with a penile urethra). The scale is useful for surgical planning and for comparing outcomes across studies, but it is not a perfect predictor of the underlying genetic severity. Research has examined whether specific mutations in the gene responsible for 21-hydroxylase deficiency (CYP21A2) predict Prader stage, and while severe mutations generally correlate with more virilization, there is enough individual variation that two people with the same mutation can end up at different stages.13PubMed. Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype One factor that may contribute to this variability is the length of a specific repeat sequence in the androgen receptor gene, which modulates how sensitive tissues are to androgens in the first place.14PubMed. The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene
The Debate Over Early Surgery
For decades, the standard approach was to perform feminizing genitoplasty in infancy, often before the child’s first birthday. The rationale was that “normalizing” the appearance of the genitalia would reduce parental anxiety and help the child develop a secure sense of gender. That rationale has come under intense scrutiny. Patient advocates and bioethicists have questioned whether irreversible surgery should be performed on an infant who cannot consent, especially when the procedure is cosmetic rather than medically necessary.15PubMed Central. Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents Some groups have called for a moratorium on all feminizing or masculinizing operations until the patient is old enough to participate in the decision.
The surgical outcomes themselves feed the controversy. Reviews of feminizing genitoplasty techniques have found that complaints of reduced clitoral sensation are linked to repeat operations, tissue removal, tissue recession, atrophy, and injuries to the nerve and blood supply of the clitoris.16PubMed. Feminizing genitoplasties: Where are we now? Modern surgical techniques attempt to preserve the nerve bundles more carefully, and outcomes from contemporary procedures may be better than those from earlier decades, but long-term data from patients who had these newer techniques in infancy are still limited. More surgical centers now distinguish between procedures that are medically indicated, such as creating a functional urinary tract, and those that are purely cosmetic, such as reducing clitoral size. The trend in many guidelines is toward deferring purely cosmetic procedures when possible.
Gender Identity
A question that weighs heavily on families is whether prenatal androgen exposure affects a child’s sense of being female. The evidence here is reassuring overall, with a few caveats. In one study of girls with classical CAH, about 88% had gender identity scores that overlapped with those of unaffected girls, though the group average was slightly shifted toward less stereotypically feminine responses. On direct questions about whether they felt uncomfortable being a girl or wished to be a boy, girls with CAH answered similarly to controls. The degree of genital virilization at birth did not predict gender identity outcomes.17The Journal of Clinical Endocrinology & Metabolism. Effects on Gender Identity of Prenatal Androgens and Genital Appearance: Evidence from Girls with Congenital Adrenal Hyperplasia
A separate study looked specifically at girls with high Prader scores (IV and V, meaning near-complete masculinization) and found that none showed a mismatch between the gender assigned at birth and their expressed identity, so long as they received good hormonal control after birth. The researchers concluded that the hormonal environment after birth had more influence on gender identity than the prenatal androgen exposure or chromosomal makeup.18PubMed Central. Gender Identity in Patients with Congenital Adrenal Hyperplasia That said, rates of gender dysphoria in people with CAH are modestly higher than in the general population, and a small minority do eventually identify as male or nonbinary. No test at birth can predict which children will follow that path, which is part of the argument for caution around irreversible early surgery.
Fertility and Pregnancy
Women with classical CAH can and do become pregnant, but fertility rates are lower than in the general population. The reasons are a mix of anatomical, hormonal, and psychosocial factors. Anatomical barriers include a narrow or absent vaginal opening from incomplete surgical reconstruction. Hormonal barriers include elevated progesterone and androgens that can interfere with ovulation. Psychosocial factors such as reduced sexual activity and delayed romantic relationships also play a role.19PubMed. Approach to the Patient: The Pregnant Woman with Congenital Adrenal Hyperplasia When pregnancies do occur, they tend to proceed normally. Optimizing cortisol-replacement therapy before conception, particularly normalizing progesterone during the first half of the menstrual cycle, is considered a key step in improving the chances of conception.20PubMed Central. Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Diagnostic Pitfalls in Adulthood
Not every case of 46,XX DSD is caught at birth. Milder forms of CAH, particularly the “simple virilizing” variant, can go unrecognized if the genital changes are subtle and newborn screening is not available or is missed. These individuals may present later in childhood with early puberty, or in adolescence and adulthood with severe acne, excess body hair, irregular periods, or failure to menstruate at all. One striking case report described a woman who was misdiagnosed at age 17 with a different condition, Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, because imaging showed a hypoplastic uterus. She was treated by multiple dermatologists for resistant acne for over a decade before an adrenal mass was discovered and endocrine testing finally revealed simple virilizing CAH confirmed by genetic sequencing.21PubMed Central. Menarche in the third decade: congenital adrenal hyperplasia masquerading as Mayer-Rokitansky-Küster-Hauser syndrome The distinction matters enormously: MRKH is a structural malformation with no hormonal driver, while CAH is a treatable hormonal condition. Getting the wrong label can mean years of unnecessary symptoms and missed fertility potential.
Other conditions that can present similarly include complete androgen insensitivity syndrome (which involves XY chromosomes, not XX, but can confuse the picture when initial karyotyping is delayed) and ovotesticular DSD, where both ovarian and testicular tissue are present. Hormone profiles help sort these out: androgen insensitivity typically shows male-range testosterone, MRKH shows completely normal female hormone levels, and ovotesticular DSD tends to have variable, non-diagnostic hormone patterns.22PubMed Central. Differences in sex development among individuals with a female phenotype and an absent uterus: Diagnostic approach
Virilization in Other Species
The phenomenon of female virilization is not unique to humans. Female spotted hyenas develop external genitalia that appear male, including an elongated clitoris through which they urinate, mate, and give birth. Research into the hyena androgen receptor found that its structure is very similar to that of other mammals and does not show unusual sensitivity to androgens, suggesting that the extreme virilization in hyenas is driven by the amount and timing of androgen exposure during development rather than by a fundamentally different receptor.
In the marine world, a form of chemically induced virilization called imposex has been documented in sea snails exposed to tributyltin (TBT), a compound once widely used in boat hull paints. Female snails develop male reproductive structures on top of their own, which can block the oviduct and cause sterilization. Studies on species like Ocinebrina aciculata showed that TBT pollution drove imposex development, progressive sterilization, and population declines.23Science of The Total Environment. Tributyltin (TBT) effects on Ocinebrina aciculata (Gastropoda: Muricidae): imposex development, sterilization, sex change and population decline The parallel is imperfect but instructive: across animal groups, androgens or androgen-like chemicals acting on female organisms during sensitive periods can redirect the development of reproductive anatomy, sometimes with severe consequences for the individual and the population.